Mersana Therapeutics Inc (MRSN)

Apr 04, 2025

MRSN stock touches 52-week low at $0.3 amid sharp annual decline - Investing.com

Apr 04, 2025

Apr 04, 2025

Mersana Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times

Apr 04, 2025

Apr 04, 2025

Mersana Strengthens Team with Strategic 26,790-Share RSU Grant to New Hire - Stock Titan

Apr 04, 2025

Apr 02, 2025

When Would Be The Best Time To Buy Mersana Therapeutics Inc (NASDAQ: MRSN) Stock? - stocksregister.com

Apr 02, 2025

Apr 01, 2025

Mersana Therapeutics Announces Upcoming Oral Presentation - GlobeNewswire

Apr 01, 2025

Apr 01, 2025

FDA Fast-Tracked Breast Cancer Drug Shows Promise: Key Clinical Data Coming at ESMO 2025 - Stock Titan

Apr 01, 2025

Mar 28, 2025

Critical Contrast: Mersana Therapeutics (NASDAQ:MRSN) & Opus Genetics (NASDAQ:IRD) - Defense World

Mar 28, 2025

Mar 27, 2025

MRSN stock plunges to 52-week low of $0.37 amid market challenges - Investing.com India

Mar 27, 2025

Mar 27, 2025

MRSN stock plunges to 52-week low of $0.37 amid market challenges By Investing.com - Investing.com South Africa

Mar 27, 2025

Mar 27, 2025

Mersana Therapeutics, Inc. (NASDAQ:MRSN) Looks Inexpensive After Falling 26% But Perhaps Not Attractive Enough - simplywall.st

Mar 27, 2025

Mar 20, 2025

MRSN stock touches 52-week low at $0.43 amid sharp decline - Investing.com India

Mar 20, 2025

Mar 13, 2025

Mersana Therapeutics, Inc. (NASDAQ:MRSN) Given Consensus Recommendation of “Moderate Buy” by Brokerages - Defense World

Mar 13, 2025

Mar 11, 2025

MRSN stock plunges to 52-week low of $0.45 amid market challenges - Investing.com Australia

Mar 11, 2025

Mar 11, 2025

Mersana at Leerink Global Healthcare Conference: Strategic ADC Insights By Investing.com - Investing.com Canada

Mar 11, 2025

Mar 11, 2025

MRSN stock plunges to 52-week low of $0.45 amid market challenges By Investing.com - Investing.com South Africa

Mar 11, 2025

Mar 10, 2025

Q1 EPS Estimates for Mersana Therapeutics Lowered by Wedbush - MarketBeat

Mar 10, 2025

Mar 08, 2025

Industry Analysts Just Made A Meaningful Upgrade To Their Mersana Therapeutics, Inc. (NASDAQ:MRSN) Revenue Forecasts - Simply Wall St

Mar 08, 2025

Mar 07, 2025

Mersana Therapeutics, Inc. to Host Earnings Call - ACCESS Newswire

Mar 07, 2025

Mar 07, 2025

Brokers Issue Forecasts for MRSN Q1 Earnings - Defense World

Mar 07, 2025

Mar 07, 2025

Q1 EPS Estimate for Mersana Therapeutics Reduced by Analyst - Defense World

Mar 07, 2025

Mar 06, 2025

Earnings Update: Mersana Therapeutics, Inc. (NASDAQ:MRSN) Just Reported And Analysts Are Boosting Their Estimates - Yahoo Finance

Mar 06, 2025

Mar 05, 2025

Industry Analysts Just Made A Captivating Upgrade To Their Mersana Therapeutics, Inc. (NASDAQ:MRSN) Revenue Forecasts - Yahoo Finance

Mar 05, 2025

Mar 04, 2025

Mersana Therapeutics, Inc. (MRSN) Reports Q4 Loss, Tops Revenue Estimates - MSN

Mar 04, 2025

Mar 04, 2025

Mersana Therapeutics, Inc. (NASDAQ:MRSN) Q4 2024 Earnings Call Transcript - Insider Monkey

Mar 04, 2025

Mar 04, 2025

Mersana Therapeutics Inc (MRSN) Q4 2024 Earnings Call Highlights: Strategic Advances and ... - Yahoo Finance

Mar 04, 2025

Mar 04, 2025

Mersana Therapeutics Inc (MRSN) Q4 2024 Earnings Call Highlights: Strategic Advances and ... By GuruFocus - Investing.com Canada

Mar 04, 2025

Mar 04, 2025

Mersana Therapeutics (NASDAQ:MRSN) Receives “Outperform” Rating from Wedbush - Defense World

Mar 04, 2025

Mar 04, 2025

Mersana Therapeutics’ Viability in Question Amidst Persistent Financial Losses and Funding Challenges - TipRanks

Mar 04, 2025

Mar 03, 2025

Mersana Therapeutics Reports Progress and Financial Results - TipRanks

Mar 03, 2025

Mar 03, 2025

Mersana Therapeutics’ Earnings Call Highlights Clinical Progress and Financial Gains - TipRanks

Mar 03, 2025

Mar 03, 2025

Earnings call transcript: Mersana Therapeutics Q4 2024 beats EPS forecast By Investing.com - Investing.com Canada

Mar 03, 2025

Mar 03, 2025

Earnings call transcript: Mersana Therapeutics Q4 2024 beats EPS forecast - Investing.com India

Mar 03, 2025

Mar 03, 2025

Mersana Therapeutics Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Mar 03, 2025

Mar 03, 2025

Mersana Therapeutics reports Q4 EPS (11c), consensus (17c) - TipRanks

Mar 03, 2025

Mar 03, 2025

Mersana Therapeutics, Inc. SEC 10-K Report - TradingView

Mar 03, 2025

Mar 03, 2025

Mersana Therapeutics earnings beat by $0.04, revenue topped estimates - Investing.com Canada

Mar 03, 2025

Mar 03, 2025

Mersana Therapeutics Announces Positive Phase 1 Clinical Data - TipRanks

Mar 03, 2025

Mar 03, 2025

Mersana Therapeutics Provides Business Update and Announces Fourth Quarter and Full Year 2024 Financial Results - GlobeNewswire

Mar 03, 2025

Mar 03, 2025

Mersana's ADC Pipeline Advances: FDA Fast Track Designation as Q4 Losses Narrow - StockTitan

Mar 03, 2025

Mar 02, 2025

What To Expect From Mersana Therapeutics Inc (MRSN) Q4 2024 Earnings - GuruFocus.com

Mar 02, 2025

Mar 01, 2025

MRSN stock touches 52-week low at $0.49 amid sharp annual decline - Investing.com Australia

Mar 01, 2025

Mar 01, 2025

William Blair starts Mersana stock with Outperform rating - MSN

Mar 01, 2025

Feb 28, 2025

Mersana Therapeutics faces Nasdaq delisting over share price By Investing.com - Investing.com South Africa

Feb 28, 2025

Feb 28, 2025

Mersana Therapeutics faces Nasdaq delisting over share price - Investing.com

Feb 28, 2025

Feb 28, 2025

MRSN stock touches 52-week low at $0.49 amid sharp annual decline By Investing.com - Investing.com South Africa

Feb 28, 2025